Damora Therapeutics
DMRA
#5408
Rank
NZ$2.62 B
Marketcap
NZ$42.45
Share price
-4.44%
Change (1 day)
42.12%
Change (1 year)

EPS for Damora Therapeutics (DMRA)

EPS in 2026 (TTM): NZ-$6.55

According to Damora Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$6.89. In 2025 the company made an earnings per share (EPS) of NZ-$7.28 an increase over its 2024 EPS that were of NZ-$33.87.

EPS history for Damora Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.55-10.03%
2025NZ-$7.28-78.52%
2024NZ-$33.87-48.64%
2023NZ-$65.95-40.61%
2022NZ-$111.0518.54%
2021NZ-$93.68-73.1%
2020NZ-$348.23131.17%
2019NZ-$150.6424.59%
2018NZ-$120.91